10 results
Treatment Algorithm for First Time DVT
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke, MD.

#DVT
Treatment Algorithm ... for First Time DVT ... #DVT #Treatment ... #Algorithm #management ... #hematology #VTE
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Thromboembolism Treatment ... Algorithm Branch ... #Management #VTE ... #DVT #Algorithm ... Thromboembolism #Treatment
Upper Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Catheter Associated

#UpperExtremity #Veins #Venous #Thrombosis
Superficial - Catheter Associated ... Superficial #Deep #VTE ... #DVT #Hematology ... Anticoagulation #Algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... of cancer-associated ... DVT = deep vein ... #Cancer #Algorithm
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... for VTE in Malignancy ... and incidental DVT ... without concomitant DVT ... risk of recurrent VTE
Algorithm for the diagnosis and management of iliofemoral deep vein thrombosis (DVT). In the absence of
Algorithm for the ... vein thrombosis (DVT ... with iliofemoral DVT ... CAT = cancer-associated ... #dvt #vte #thromboembolism
Recurrent Polymorphic VT/Torsades de Pointes - Management Algorithm
Drugs that prolong QT interval:
 • Class 1a (quinidine,
Recurrent Polymorphic VT ... Pointes - Management Algorithm ... Hypocalcemia (rarely) Treatment ... TDP #Management #Algorithm
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment ... Algorithm Treat ... Isolated distal DVT ... Unprovoked proximal DVT ... therapy - Second VTE
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

https://www.nejm.org/doi/full/10.1056/NEJMoa1711948

Authors’ Conclusions: “Oral edoxaban was noninferior to subcutaneous dalteparin
Edoxaban for the Treatment ... of Cancer-Associated ... respect to recurrent VTE ... VenousThromboembolism #VTE ... VisualAbstract #DVT
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/ ... Demonstration of an ET-associated ... hemoproliferative disorder associated ... • Treatment is ... • Treatment algorithms